BIOLAB A/S
CVR number: 35445315
Sindalsvej 29, 8240 Risskov
ema@biolab.dk
tel: 86212866
Income statement (kDKK)
| 2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|
| Fiscal period length | 12 | 12 | 12 | 12 | 12 |
| Net sales | |||||
| Gross profit | 8 647.34 | 9 146.93 | 9 408.27 | 8 555.00 | 9 799.77 |
| Employee benefit expenses | -6 780.48 | -6 976.97 | -6 842.12 | -6 786.00 | -7 014.74 |
| Total depreciation | -29.18 | -23.53 | -27.70 | -17.00 | -10.60 |
| EBIT | 1 837.69 | 2 146.43 | 2 538.45 | 1 752.00 | 2 774.42 |
| Other financial income | 33.14 | 278.71 | 14.54 | 54.00 | 110.38 |
| Other financial expenses | -38.39 | -27.52 | -18.77 | -13.00 | -8.92 |
| Pre-tax profit | 1 832.43 | 2 397.62 | 2 534.22 | 1 793.00 | 2 875.89 |
| Income taxes | - 406.09 | - 529.20 | - 559.62 | - 395.00 | - 634.20 |
| Net earnings | 1 426.34 | 1 868.42 | 1 974.60 | 1 398.00 | 2 241.69 |
Assets (kDKK)
| 2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|
| Intangible assets total | |||||
| Machinery and equipment | 60.18 | 36.66 | 72.00 | 54.00 | 44.07 |
| Tangible assets total | 60.18 | 36.66 | 72.00 | 54.00 | 44.07 |
| Investments total | |||||
| Long term receivables total | |||||
| Finished products/goods | 3 726.36 | 3 607.16 | 3 793.63 | 4 003.00 | 3 578.37 |
| Advance payments | 127.69 | ||||
| Inventories total | 3 726.36 | 3 607.16 | 3 793.63 | 4 003.00 | 3 706.07 |
| Current trade debtors | 1 989.18 | 1 500.25 | 3 165.10 | 1 278.00 | 4 845.56 |
| Prepayments and accrued income | 25.89 | 92.36 | 98.05 | 56.00 | |
| Current other receivables | 1 209.65 | 2 403.47 | 362.66 | 235.00 | 235.94 |
| Current deferred tax assets | 15.31 | 6.02 | 0.90 | 17.00 | 16.69 |
| Short term receivables total | 3 240.03 | 4 002.10 | 3 626.71 | 1 586.00 | 5 098.19 |
| Cash and bank deposits | 3 601.40 | 2 682.33 | 529.65 | 2 775.00 | 2 335.15 |
| Cash and cash equivalents | 3 601.40 | 2 682.33 | 529.65 | 2 775.00 | 2 335.15 |
| Balance sheet total (assets) | 10 627.97 | 10 328.26 | 8 021.99 | 8 418.00 | 11 183.48 |
Equity and liabilities (kDKK)
| 2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|
| Share capital | 500.00 | 500.00 | 500.00 | 500.00 | 500.00 |
| Shares repurchased | 500.00 | 1 300.00 | 900.00 | 600.00 | 800.00 |
| Other reserves | - 800.00 | ||||
| Retained earnings | 1 537.97 | 664.32 | 1 132.74 | 2 507.00 | 3 105.59 |
| Profit of the financial year | 1 426.34 | 1 868.42 | 1 974.60 | 1 398.00 | 2 241.69 |
| Shareholders equity total | 3 964.32 | 4 332.74 | 4 507.34 | 5 005.00 | 5 847.28 |
| Provisions | 1.10 | 0.00 | |||
| Non-current other liabilities | 531.77 | 630.58 | |||
| Non-current deferred tax liabilities | 310.98 | 430.52 | 479.62 | 315.00 | 512.48 |
| Non-current liabilities total | 842.75 | 1 061.11 | 479.62 | 315.00 | 512.48 |
| Current trade creditors | 441.08 | 375.57 | 556.95 | 493.00 | 1 190.98 |
| Other non-interest bearing current liabilities | 4 096.76 | 3 438.37 | 1 278.93 | 1 225.00 | 2 261.66 |
| Accruals and deferred income | 1 283.06 | 1 119.37 | 1 199.15 | 1 380.00 | 1 371.08 |
| Current liabilities total | 5 820.90 | 4 933.31 | 3 035.03 | 3 098.00 | 4 823.72 |
| Balance sheet total (liabilities) | 10 627.97 | 10 328.26 | 8 021.99 | 8 418.00 | 11 183.48 |
Try the full version of our system for free
Create your own estimates for any company
Valuation analysis
See instructions
... and more!
No registration needed.